300630 普利制药
2023/09 - 九个月2022/122021/122020/122019/12

盈利能力分析
净资产收益率 ROE (%)13.60215.74118.18925.58529.681
总资产报酬率 ROA (%)6.3947.92010.79517.06121.288
投入资产回报率 ROIC (%)7.0398.83012.36519.87724.577

边际利润分析
销售毛利率 (%)67.63465.84571.57774.75881.606
营业利润率 (%)30.39324.33131.02438.51635.104
息税前利润/营业总收入 (%)32.42626.06733.95039.29335.617
净利润/营业总收入 (%)29.89923.28527.61134.28031.697

收益指标分析
经营活动净收益/利润总额(%)93.27596.652101.20296.54796.871
价值变动净收益/利润总额(%)1.105-0.341-0.7590.063-0.629
营业外收支净额/利润总额(%)-0.013-0.133-0.118-0.7840.191

偿债能力分析
流动比率 (X)1.9291.6461.9481.8281.566
速动比率 (X)1.6431.4291.6961.6881.405
资产负债率 (%)53.01052.97045.4820.33333.387
带息债务/全部投入资本 (%)44.67644.39434.90315.77217.664
股东权益/带息债务 (%)115.258117.250175.795498.001431.458
股东权益/负债合计 (%)88.64588.785119.867200.536199.514
利息保障倍数 (X)15.92214.74111.45736.52179.975

营运能力分析
应收账款周转天数 (天)231.199179.350175.854140.73388.662
存货周转天数 (天)223.966170.583149.53198.272145.093